Regencell Bioscience is a holding company. Through its subsidiaries, Co. is an early-stage bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder, and infectious diseases affecting people's immune system such as COVID. When considering the Regencell Bioscience Holdings Ltd stock dividend history, we have taken known splits into account, such that the RGC dividend history is presented on a split-adjusted ("apples to apples") basis. Regencell Bioscience Holdings Ltd dividend history is presented both in graphical/chart form, and as a RGC dividend history data table along the right-hand column.
|
RGC Stock Dividend HistoryThe RGC dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable RGC historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the RGC dividend history record. Also see the RGC stock dividend history data table along the right-hand column below. |
|
RGC Next Dividend Date » (Projection based upon history) Quotes delayed 20 minutes |
Hold (2.17 out of 4) 83rd percentile
(ranked higher than approx. 83% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
Projection: RGC Next Dividend Date Chart: RGC Chart - 5Yr Dividend Yield |